2020
DOI: 10.1038/s41598-020-76896-4
|View full text |Cite
|
Sign up to set email alerts
|

Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy

Abstract: This study aimed to evaluate the potential of oral probiotics to eradicate vaginal GBS colonization during the third trimester of pregnancy. We screened 1058 women for GBS colonization at 33–37 gestational weeks using a combination of vaginal-to-rectal swab and culture-based methods. Women who tested GBS positive were randomized to either the verum group, receiving a dietary probiotic supplement of four viable strains of Lactobacillus twice-daily for 14 days, or to the placebo group. Women underwent follow-up … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 39 publications
(38 reference statements)
0
18
1
Order By: Relevance
“…Probiotics with their antimicrobial potential could be used to support healthy gut and VMB and thus reduce GBS colonization. No impact on GBS colonization was found with consumption of four-strain probiotic blend L. jensenii Lbv116, L. crispatus Lbv88, L. rhamnosus Lbv96, and L. gasseri Lbv150 when consumed for 2 weeks in GBS-positive women with 33-37 weeks of gestation (Farr et al, 2020). Furthermore, no significant impact on GBS colonization was observed in an open-label trial of 10 women with a probiotic combination containing L. acidophilus strains La-14 and NCFM, Bifidobacterium animalis subsp.…”
Section: Probioticsmentioning
confidence: 89%
“…Probiotics with their antimicrobial potential could be used to support healthy gut and VMB and thus reduce GBS colonization. No impact on GBS colonization was found with consumption of four-strain probiotic blend L. jensenii Lbv116, L. crispatus Lbv88, L. rhamnosus Lbv96, and L. gasseri Lbv150 when consumed for 2 weeks in GBS-positive women with 33-37 weeks of gestation (Farr et al, 2020). Furthermore, no significant impact on GBS colonization was observed in an open-label trial of 10 women with a probiotic combination containing L. acidophilus strains La-14 and NCFM, Bifidobacterium animalis subsp.…”
Section: Probioticsmentioning
confidence: 89%
“…Moreover, there is striking evidence for an increased risk of PTB through vaginal infections, as well as for an association between the oral and the vaginal microbiome (e.g., low hygiene status is associated with increased bv risk) [ 89 , 90 ]. Indeed, an antenatal infection screen-and-treat program might be useful in routine pregnancy care to prevent PTB, LBW, and adverse pregnancy outcomes [ 89 , 91 ].…”
Section: Discussionmentioning
confidence: 99%
“…The population was Caucasian in three studies [ 33 , 35 , 36 ] while one study also included Hispanic and other ethnicities [ 34 ]; the remnant one was conducted on Asian women [ 32 ]. The sample size ranged from 34 to 151 pregnant women.…”
Section: Resultsmentioning
confidence: 99%
“…All of the included studies tested oral supplementation with probiotics. Probiotic strains were the same in four of the studies ( Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 L ) [ 32 , 33 , 34 , 35 ], while Lactobacillus jensenii Lbv116 , Lactobacillus crispatus Lbv88 , Lactobacillus rhamnosus Lbv96 , and Lactobacillus gasseri Lbv150 were used in the remnant study [ 36 ]. Doses ranged from 1 ×108 CFU to 5.4 ×109 CFU daily.…”
Section: Resultsmentioning
confidence: 99%